Navigation Links
Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
Date:6/24/2011

CHICAGO, June 24, 2011 /PRNewswire/ -- Identifying successful strategies for specialty pharmacy benefit programs can assist in creating optimal program management, Prime Therapeutics Vice President of Specialty Pharmacy Solutions Elizabeth Mauer and Blue Cross Blue Shield of Florida Senior Director of Clinical Pharmacy Programs Beckie Fenrick told participants at a pre-conference workshop at the 6th Annual Executive Forum on Pharmacy Benefit Management Strategies today.

"Assessing current specialty pharmacy approaches and examining efficient program monitoring and evaluation tools can help improve programs and close gaps," said Mauer. "Greater competition, new tools for specialty management, improved understanding of the cost/quality equation, a greater focus on patient outcomes and improved coordination across the health care spectrum will all change how we manage specialty benefits in the years ahead."

Specialty pharmaceuticals treat complex or chronic illnesses and many of these medications are "biologic" drugs, requiring a complex production process. Spending on specialty medications is increasing at twice the rate of the overall drug market, reaching an average annual cost of $32,735 in 2009.(1)

"Understanding the current and future specialty pharmaceutical landscape is a key imperative for payers for which the importance will continue to grow," said Fenrick. "New innovative medication introductions will bring more competition to the specialty space and appropriate medication management will become more complex. Add to that the regulatory and market changes we will see with health care reform a successful specialty pharmacy management strategy becomes a key factor for payers in the short and long term."

Mauer and Fenrick also spoke about the forces driving growth of specialty spending and identified the four keys for effective specialty pharmacy management: distribution channel, utilization management, care management and contracting activities.

Delivered to an audience of health plan executives, large self-insured employer executives and other experts within the industry, Mauer and Fenrick's presentation was the meeting's only pre-conference workshop.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members.

Providing pharmacy benefit services nationwide to nearly 17 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.

(1) Stephen W. Schondelmeyer, PRIME Institute, University of Minnesota, Leigh Purvis, AARP Public Policy Institute, and David J. Gross, AARP Office of Policy and Integration. "Rx Watchdog Report: Drug Prices Continue to Climb Despite Lack of Growth in General Inflation Rate." Insight on the Issues 36, November 2009. http://assets.aarp.org/rgcenter/ppi/health-care/i36-watchdog.pdf.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardinal Health, Prime Therapeutics Renew Primary Distribution Agreement
2. BGI Releases a Complete De Novo E. Coli O104 Genome Assembly and is Making Its Detection Kit Protocols and Synthesized Primers Freely Available to Worldwide Disease Control and Research Agencies
3. TriLink BioTechnologies, Inc. Awarded European Patent for CleanAmp™ Primers
4. Prime Therapeutics President and CEO Eric Elliott Delivers Speech at University of Minnesota College of Pharmacy Dialogues in Managed Care Leadership 2011
5. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
6. Volcano Announces the Introduction of the PrimeWire PRESTIGE® Pressure Guide Wire in Japan
7. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference
8. Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
9. Greenways PrimeSUITE EHR Featured at IHE North America Connectathon
10. Greenways PrimeSUITE Endorsed by Allina Hospitals & Clinics
11. Prime Healthcare Converts System-Wide to Masimo rainbow SET Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017 Shire plc (LSE: SHP, ... Food and Drug Administration (FDA) has acknowledged receipt of ... (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine salts ... treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected ... 2017, the designated Prescription Drug User Fee Act (PDUFA) ...
(Date:1/19/2017)... 19, 2017 While various ... about reducing the FDA,s regulatory strictness as a ... medical drug industry, many of the leading biotech ... trials and development of advanced drug treatments and ... recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
(Date:1/19/2017)... The Global Therapy Partnering Terms and Agreements ... deals and agreements entered into by the world,s leading ... Top deals by value - Deals listed by company ... The report provides understanding and access to the partnering ... healthcare companies. The report provides an analysis of ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... ... Cosmetic Town, an online plastic surgery community, begins 2017 with an update ... their readers to get the information they desire. The procedures are now listed according ... on those particular areas. , “We are excited to streamline our listings in a ...
(Date:1/19/2017)... ... 2017 , ... MB Business Capital, a division of MB ... to Sunrise, Florida-based Management Health Systems, LLC, dba MedPro Healthcare Staffing (“MedPro”). Proceeds ... MedPro led by Harren Equity Partners. Brightwood Capital Advisors provided a new ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... for patients with sleep apnea and TMJ disorders. These conditions are quite common ... Dr. Rassouli provides personalized care to reduce the risk of these consequences and ...
(Date:1/19/2017)... ... 2017 , ... Sam & Associates Insurance Agency, a full service firm providing ... California Bay Area, is launching a charity drive to raise awareness of heart disease ... the primary killer of adult men and women in America, and is responsible for ...
(Date:1/19/2017)... ... ... St. Catherine’s Village announced that a limited number of rooms have become available ... grounds of the St. Catherine’s Village campus in Madison, Mississippi that accommodates 120 residents ... Mississippi for the second year in a row by readers of the Clarion-Ledger. , ...
Breaking Medicine News(10 mins):